Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag
- 19 February 2007
- Vol. 25 (9), 1634-1646
- https://doi.org/10.1016/j.vaccine.2006.11.004
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- HSV-1-based amplicon vectors: design and applicationsGene Therapy, 2005
- Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in miceVaccine, 2005
- Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccineVaccine, 2005
- Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemiaGene Therapy, 2005
- HSV amplicon-mediated Aβ vaccination in Tg2576 mice: differential antigen-specific immune responsesNeurobiology of Aging, 2005
- Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidateVaccine, 2005
- Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in MiceJournal of Virology, 2005
- Comparative Immunogenicity of Human Immunodeficiency Virus Particles and Corresponding Polypeptides in a DNA VaccineJournal of Virology, 2005
- Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responsesMolecular Immunology, 2004
- Helper Virus-Free Herpes Simplex Virus Type 1 Amplicon Vectors for Granulocyte-Macrophage Colony-Stimulating Factor-Enhanced Vaccination Therapy for Experimental GliomaHuman Gene Therapy, 2000